These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21150370)

  • 1. The context and approach for the California newborn screening short- and long-term follow-up data system: preliminary findings.
    Feuchtbaum L; Dowray S; Lorey F
    Genet Med; 2010 Dec; 12(12 Suppl):S242-50. PubMed ID: 21150370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up data collection and use in state newborn screening programs.
    Hoff T; Ayoob M; Therrell BL
    Arch Pediatr Adolesc Med; 2007 Oct; 161(10):994-1000. PubMed ID: 17909144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newborn dried bloodspot screening: long-term follow-up activities and information system requirements.
    Singh RH; Hinman AR
    Genet Med; 2010 Dec; 12(12 Suppl):S261-6. PubMed ID: 21150373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up to ensure quality care of individuals diagnosed with newborn screening conditions: early experience in New England.
    Sahai I; Eaton RB; Hale JE; Mulcahy EA; Comeau AM
    Genet Med; 2010 Dec; 12(12 Suppl):S220-7. PubMed ID: 21150368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of newborn screening patients.
    Berry SA; Lloyd-Puryear MA; Watson MS
    Genet Med; 2010 Dec; 12(12 Suppl):S267-8. PubMed ID: 21150374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up in newborn screening: A systems approach for improving health outcomes.
    Lloyd-Puryear MA; Brower A
    Genet Med; 2010 Dec; 12(12 Suppl):S256-60. PubMed ID: 21150372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newborn dried bloodspot screening: mapping the clinical and public health components and activities.
    Hinman AR; Mann MY; Singh RH;
    Genet Med; 2009 Jun; 11(6):418-24. PubMed ID: 19369886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newborn screening residual dried blood spot use for newborn screening quality improvement.
    Benkendorf J; Goodspeed T; Watson MS
    Genet Med; 2010 Dec; 12(12 Suppl):S269-72. PubMed ID: 21150375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of children with confirmed newborn screening disorders using record linkage.
    Wang Y; Caggana M; Sango-Jordan M; Sun M; Druschel CM
    Genet Med; 2011 Oct; 13(10):881-6. PubMed ID: 21637103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What questions should newborn screening long-term follow-up be able to answer? A statement of the US Secretary for Health and Human Services' Advisory Committee on Heritable Disorders in Newborns and Children.
    Hinton CF; Feuchtbaum L; Kus CA; Kemper AR; Berry SA; Levy-Fisch J; Luedtke J; Kaye C; Boyle CA
    Genet Med; 2011 Oct; 13(10):861-5. PubMed ID: 21716119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing a public health-tracking system for follow-up of newborn screening metabolic conditions: a four-state pilot project structure and initial findings.
    Hinton CF; Mai CT; Nabukera SK; Botto LD; Feuchtbaum L; Romitti PA; Wang Y; Piper KN; Olney RS
    Genet Med; 2014 Jun; 16(6):484-90. PubMed ID: 24310309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examination of the communication practices between state newborn screening programs and the medical home.
    Kim S; Lloyd-Puryear MA; Tonniges TF
    Pediatrics; 2003 Feb; 111(2):E120-6. PubMed ID: 12563084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. California's experience implementing a pilot newborn supplemental screening program using tandem mass spectrometry.
    Feuchtbaum L; Lorey F; Faulkner L; Sherwin J; Currier R; Bhandal A; Cunningham G
    Pediatrics; 2006 May; 117(5 Pt 2):S261-9. PubMed ID: 16735252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up culture in state newborn screening programs.
    Hoff T
    Genet Med; 2008 Jun; 10(6):396-403. PubMed ID: 18496218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newborn screening in Wisconsin: program overview and test addition.
    Ciske JB; Hoffman G; Hanson K; Annable KM; Wolff J; Litsheim T; Laessig R; Aronson R
    WMJ; 2000 Apr; 99(2):38-42. PubMed ID: 10843023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring and assessment in maternal and child health: recommendations for action at the state level.
    Peoples MD; Miller CA
    J Health Polit Policy Law; 1983; 8(2):251-76. PubMed ID: 6619533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population based surveillance in sickle cell disease: methods, findings and implications from the California registry and surveillance system in hemoglobinopathies project (RuSH).
    Paulukonis ST; Harris WT; Coates TD; Neumayr L; Treadwell M; Vichinsky E; Feuchtbaum LB
    Pediatr Blood Cancer; 2014 Dec; 61(12):2271-6. PubMed ID: 25176145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating a program to build data capacity for core public health functions in local maternal child and adolescent health programs in california.
    Oliva G; Rienks J; Chavez GF
    Matern Child Health J; 2007 Jan; 11(1):1-10. PubMed ID: 17006772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Birth prevalence of disorders detectable through newborn screening by race/ethnicity.
    Feuchtbaum L; Carter J; Dowray S; Currier RJ; Lorey F
    Genet Med; 2012 Nov; 14(11):937-45. PubMed ID: 22766612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newborn screening in Australia and New Zealand.
    Webster D; ;
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():69-70. PubMed ID: 15906698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.